Cognitive-behavioral therapy for the management of irritable bowel syndrome

World Journal of Gastroenterology

Volumn 19, Issue 46, 2013, Pages 8605-8610

  Tang, Qing Lin ^a,b   Lin, Guo Yao ^b   Zhang, Ming Qing ^a  

^a Digestive Endoscopy Center of Nanjing Military Command   (China)

^b MINNAN NORMAL UNIVERSITY   (China)

Author keywords

Cognitive behavioral therapy; Irritable bowel syndrome; Psychological treatment

Indexed keywords

ANXIETY; COGNITIVE THERAPY; DOCTOR PATIENT RELATION; EDUCATION; HUMAN; IRRITABLE COLON; REVIEW; STRESS MANAGEMENT; TRAINING;

COGNITIVE-BEHAVIORAL THERAPY; IRRITABLE BOWEL SYNDROME; PSYCHOLOGICAL TREATMENT;

COGNITIVE THERAPY; HUMANS; IRRITABLE BOWEL SYNDROME; TREATMENT OUTCOME;

EID: 84890356805     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i46.8605     Document Type: Review

References (66)

1. El-Salhy M. Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol 2012; 18: 5151-5163 [PMID: 23066308 DOI: 10.3748/wjg.v18.i37.5151]
2. Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 2009; 58: 367-378 [PMID: 19001059 DOI: 10.1136/ gut.2008.163162]
3. Camilleri M. Peripheral mechanisms in irritable bowel syndrome. N Engl J Med 2012; 367: 1626-1635 [PMID: 23094724 DOI: 10.1056/NEJMra1207068]
4. Andrews EB, Eaton SC, Hollis KA, Hopkins JS, Ameen V, Hamm LR, Cook SF, Tennis P, Mangel AW. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment Pharmacol Ther 2005; 22: 935-942 [PMID: 16268967 DOI: 10.1111/ j.1365-2036.2005.02671.x]
5. Dean BB, Aguilar D, Barghout V, Kahler KH, Frech F, Groves D, Ofman JJ. Impairment in work productivity and healthrelated quality of life in patients with IBS. Am J Manag Care 2005; 11: S17-S26 [PMID: 15926760]
6. Longstreth GF, Bolus R, Naliboff B, Chang L, Kulich KR, Carlsson J, Mayer EA, Naesdal J, Wiklund IK. Impact of irritable bowel syndrome on patients' lives: development and psychometric documentation of a disease-specific measure for use in clinical trials. Eur J Gastroenterol Hepatol 2005; 17: 411-420 [PMID: 15756093 DOI: 10.1097/00042737-20050400000004]
7. Leong SA, Barghout V, Birnbaum HG, Thibeault CE, BenHamadi R, Frech F, Ofman JJ. The economic consequences of irritable bowel syndrome: a US employer perspective. Arch Intern Med 2003; 163: 929-935 [PMID: 12719202 DOI: 10.1001/ archinte.163.8.929]
8. Martin R, Barron JJ, Zacker C. Irritable bowel syndrome: toward a cost-effective management approach. Am J Manag Care 2001; 7: S268-S275 [PMID: 11474912]
9. Spiegel BM. The burden of IBS: looking at metrics. Curr Gastroenterol Rep 2009; 11: 265-269 [PMID: 19615301]
10. Mayer EA. Clinical practice. Irritable bowel syndrome. N Engl J Med 2008; 358: 1692-1699 [PMID: 18420501 DOI: 10.1056/NEJMcp0801447]
11. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997; 112: 2120-2137 [PMID: 9178709 DOI: 10.1053/gast.1997.v112.agast972120]
12. Halland M, Talley NJ. New treatments for IBS. Nat Rev Gastroenterol Hepatol 2013; 10: 13-23 [PMID: 23147658 DOI: 10.1038/nrgastro.2012.207]
13. Miller V, Hopkins L, Whorwell PJ. Suicidal ideation in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2004; 2: 1064-1068 [PMID: 15625650 DOI: 10.1053/ s1542-3565(04)00545-2]
14. Wilson A, Longstreth GF, Knight K, Wong J, Wade S, Chiou CF, Barghout V, Frech F, Ofman JJ. Quality of life in managed care patients with irritable bowel syndrome. Manag Care Interface 2004; 17: 24-28+34 [PMID: 15038690]
15. Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 2000; 95: 67-71 [PMID: 10638561]
16. Malagelada JR. A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation. Int J Clin Pract 2006; 60: 57-63 [PMID: 16409429 DOI: 10.1111/j.1368-5031.2005.00744.x]
17. Khan S, Chang L. Diagnosis and management of IBS. Nat Rev Gastroenterol Hepatol 2010; 7: 565-581 [PMID: 20890316 DOI: 10.1038/nrgastro.2010.137]
18. Surdea-Blaga T, Bǎban A, Dumitrascu DL. Psychosocial determinants of irritable bowel syndrome. World J Gastroenterol 2012; 18: 616-626 [PMID: 22363132 DOI: 10.3748/wjg. v18.i7.616]
19. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-1491 [PMID: 16678561 DOI: 10.1053/ j.gastro.2005.11.061]
20. Gaylord SA, Palsson OS, Garland EL, Faurot KR, Coble RS, Mann JD, Frey W, Leniek K, Whitehead WE. Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial. Am J Gastroenterol 2011; 106: 1678-1688 [PMID: 21691341 DOI: 10.1038/ ajg.2011.184]
21. Whitehead WE, Levy RL, Von Korff M, Feld AD, Palsson OS, Turner M, Drossman DA. The usual medical care for irritable bowel syndrome. Aliment Pharmacol Ther 2004; 20: 1305-1315 [PMID: 15606392 DOI: 10.1111/j.1365-2036.2004.02256.x]
22. Zijdenbos IL, de Wit NJ, van der Heijden GJ, Rubin G, Quartero AO. Psychological treatments for the management of irritable bowel syndrome. Cochrane Database Syst Rev 2009; (1): CD006442 [PMID: 19160286 DOI: 10.1002/14651858. CD006442.pub2]
23. Rush AJ, Beck AT. Cognitive therapy of depression and suicide. Am J Psychother 1978; 32: 201-219 [PMID: 677351]
24. Hutton J. Cognitive behaviour therapy for irritable bowel syndrome. Eur J Gastroenterol Hepatol 2005; 17: 11-14 [PMID: 15647633 DOI: 10.1097/00042737-200501000-00003]
25. Reme SE, Stahl D, Kennedy T, Jones R, Darnley S, Chalder T. Mediators of change in cognitive behaviour therapy and mebeverine for irritable bowel syndrome. Psychol Med 2011; 41: 2669-2679 [PMID: 21477419 DOI: 10.1017/s0033291711000328]
26. Van Oudenhove L, Vandenberghe J, Demyttenaere K, Tack J. Psychosocial factors, psychiatric illness and functional gastrointestinal disorders: a historical perspective. Digestion 2010; 82: 201-210 [PMID: 20588034 DOI: 10.1159/000269822]
27. Lea R, Whorwell PJ. New insights into the psychosocial aspects of irritable bowel syndrome. Curr Gastroenterol Rep 2003; 5: 343-350 [PMID: 12864966 DOI: 10.1007/s11894-0030073-z]
28. Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, Jones R, Kumar D, Rubin G, Trudgill N, Whorwell P. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007; 56: 1770-1798 [PMID: 17488783 DOI: 10.1136/gut.2007.119446]
29. White DL, Savas LS, Daci K, Elserag R, Graham DP, Fitzgerald SJ, Smith SL, Tan G, El-Serag HB. Trauma history and risk of the irritable bowel syndrome in women veterans. Aliment Pharmacol Ther 2010; 32: 551-561 [PMID: 20528828 DOI: 10.1111/j.1365-2036.2010.04387.x]
30. Wilkins T, Pepitone C, Alex B, Schade RR. Diagnosis and management of IBS in adults. Am Fam Physician 2012; 86: 419-426 [PMID: 22963061]
31. Creed F, Guthrie E. Psychological factors in the irritable bowel syndrome. Gut 1987; 28: 1307-1318 [PMID: 3315878 DOI: 10.1136/gut.28.10.1307]
32. Nicholl BI, Halder SL, Macfarlane GJ, Thompson DG, O'Brien S, Musleh M, McBeth J. Psychosocial risk markers for new onset irritable bowel syndrome--results of a large prospective population-based study. Pain 2008; 137: 147-155 [PMID: 17928145 DOI: 10.1016/j.pain.2007.08.029]
33. Lackner JM, Gudleski GD, Haroon M, Krasner SS, Katz LA, Firth RS, Sitrin MD, Radziwon C, Wurl A. Proactive Screening for Psychosocial Risk Factors in Moderate to Severe Patients with Irritable Bowel Syndrome: The Predictive Validity of the Rome III Psychosocial Alarm Questionnaire. Neuroenterology 2012; 1: 1-7 [DOI: 10.4303/ne/235546]
34. Blanchard EB, Lackner JM, Sanders K, Krasner S, Keefer L, Payne A, Gudleski GD, Katz L, Rowell D, Sykes M, Kuhn E, Gusmano R, Carosella AM, Firth R, Dulgar-Tulloch L. A controlled evaluation of group cognitive therapy in the treatment of irritable bowel syndrome. Behav Res Ther 2007; 45: 633-648 [PMID: 16979581 DOI: 10.1016/j.brat.2006.07.003]
35. Lackner JM, Jaccard J, Krasner SS, Katz LA, Gudleski GD, Holroyd K. Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: clinical efficacy, tolerability, feasibility. Clin Gastroenterol Hepatol 2008; 6: 899-906 [PMID: 18524691 DOI: 10.1016/j.cgh.2008.03.004]
36. Kuyken W, Dalgleish T, Holden ER. Advances in cognitivebehavioural therapy for unipolar depression. Can J Psychiatry 2007; 52: 5-13 [PMID: 17444073]
37. Beck AT. How an anomalous finding led to a new system of psychotherapy. Nat Med 2006; 12: 1139-1141 [PMID: 17024209 DOI: 10.1038/nm1006-1139]
38. Thoma NC, McKay D, Gerber AJ, Milrod BL, Edwards AR, Kocsis JH. A quality-based review of randomized controlled trials of cognitive-behavioral therapy for depression: an assessment and metaregression. Am J Psychiatry 2012; 169: 22-30 [PMID: 22193528 DOI: 10.1176/appi.ajp.2011.11030433]
39. Boyce P, Gilchrist J, Talley NJ, Rose D. Cognitive-behaviour therapy as a treatment for irritable bowel syndrome: a pi lot study. Aust N Z J Psychiatry 2000; 34: 300-309 [PMID: 10789535 DOI: 10.1080/j.1440-1614.2000.00731.x]
40. Craske MG, Wolitzky-Taylor KB, Labus J, Wu S, Frese M, Mayer EA, Naliboff BD. A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther 2011; 49: 413-421 [PMID: 21565328 DOI: 10.1016/j.brat.2011.04.001]
41. Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med 1995; 122: 107-112 [PMID: 7992984]
42. Lackner JM, Gudleski GD, Keefer L, Krasner SS, Powell C, Katz LA. Rapid response to cognitive behavior therapy predicts treatment outcome in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2010; 8: 426-432 [PMID: 20170751 DOI: 10.1016/j.cgh.2010.02.007]
43. Reme SE, Kennedy T, Jones R, Darnley S, Chalder T. Predictors of treatment outcome after cognitive behavior therapy and antispasmodic treatment for patients with irritable bowel syndrome in primary care. J Psychosom Res 2010; 68: 385-388 [PMID: 20307706 DOI: 10.1016/j.jpsychores.2010.01.003]
44. Drossman DA, Toner BB, Whitehead WE, Diamant NE, Dalton CB, Duncan S, Emmott S, Proffitt V, Akman D, Frusciante K, Le T, Meyer K, Bradshaw B, Mikula K, Morris CB, Blackman CJ, Hu Y, Jia H, Li JZ, Koch GG, Bangdiwala SI. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 2003; 125: 19-31 [PMID: 12851867 DOI: 10.1016/s0016-5085(03)00669-3]
45. Greene B, Blanchard EB. Cognitive therapy for irritable bowel syndrome. J Consult Clin Psychol 1994; 62: 576-582 [PMID: 8063984 DOI: 10.1037//0022-006x.62.3.576]
46. Payne A, Blanchard EB. A controlled comparison of cognitive therapy and self-help support groups in the treatment of irritable bowel syndrome. J Consult Clin Psychol 1995; 63: 779-786 [PMID: 7593870 DOI: 10.1037//0022-006x.63.5.779]
47. Tkachuk GA, Graff LA, Martin GL, Bernstein CN. Randomized controlled trial of cognitive-behavioral group therapy for irritable bowel syndrome in a medical setting. J Clin Psychol In Med Settings 2003; 10: 57-69 [DOI: 10.1023/a: 1022809914863]
48. Vollmer A, Blanchard EB. Controlled comparison of individual versus group cognitive therapy for irritable bowel syndrome. Behavior Therapy 1998; 29: 19-33 [DOI: 10.1016/ s0005-7894(98)80016-6]
49. Kennedy T, Jones R, Darnley S, Seed P, Wessely S, Chalder T. Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial. BMJ 2005; 331: 435 [PMID: 16093252 DOI: 10.1136/bmj.38545.505764.06]
50. Boyce PM, Talley NJ, Balaam B, Koloski NA, Truman G. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome. Am J Gastroenterol 2003; 98: 2209-2218 [PMID: 14572570 DOI: 10.1016/s0002-9270(03)00749-4]
51. Palsson OS, Whitehead WE. Psychological treatments in functional gastrointestinal disorders: a primer for the gastroenterologist. Clin Gastroenterol Hepatol 2013; 11: 208-216; quiz e22-3[PMID: 23103907 DOI: 10.1016/j.cgh.2012.10.031]
52. Lynch PM, Zamble E. A controlled behavioral treatment study of Irritable Bowel syndrome. Behavior Therapy 1989; 20: 509-523 [DOI: 10.1016/s0005-7894(89)80130-3]
53. Heymann-Mönnikes I, Arnold R, Florin I, Herda C, Melfsen S, Mönnikes H. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 981-994 [PMID: 10763948]
54. Sanders KA, Blanchard EB, Sykes MA. Preliminary study of a self-administered treatment for irritable bowel syndrome: comparison to a wait list control group. Appl Psychophysiol Biofeedback 2007; 32: 111-119 [PMID: 17564825 DOI: 10.1007/ s10484-007-9037-7]
55. Hunt MG, Moshier S, Milonova M. Brief cognitive-behavioral internet therapy for irritable bowel syndrome. Behav Res Ther 2009; 47: 797-802 [PMID: 19570525]
56. Moss-Morris R, McAlpine L, Didsbury LP, Spence MJ. A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care. Psychol Med 2010; 40: 85-94 [PMID: 19531276 DOI: 10.1017/s0033291709990195]
57. Ljótsson B, Hedman E, Andersson E, Hesser H, Lindfors P, Hursti T, Rydh S, Rück C, Lindefors N, Andersson G. Internet-delivered exposure-based treatment vs. stress management for irritable bowel syndrome: a randomized trial. Am J Gastroenterol 2011; 106: 1481-1491 [PMID: 21537360 DOI: 10.1038/ajg.2011.139]
58. Ljótsson B, Andersson G, Andersson E, Hedman E, Lindfors P, Andréewitch S, Rück C, Lindefors N. Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial. BMC Gastroenterol 2011; 11: 110 [PMID: 21992655 DOI: 10.1186/1471-230x-11-110]
59. Oerlemans S, van Cranenburgh O, Herremans PJ, Spreeuwenberg P, van Dulmen S. Intervening on cognitions and behavior in irritable bowel syndrome: A feasibility trial using PDAs. J Psychosom Res 2011; 70: 267-277 [PMID: 21334498 DOI: 10.1016/j.jpsychores.2010.09.018]
60. Hungin AP. Self-help interventions in irritable bowel syndrome. Gut 2006; 55: 603-604 [PMID: 16609132 DOI: 10.1136/ gut.2005.075606]
61. Lackner JM, Jaccard J, Krasner SS, Katz LA, Gudleski GD, Blanchard EB. How does cognitive behavior therapy for irritable bowel syndrome work? A mediational analysis of a randomized clinical trial. Gastroenterology 2007; 133: 433-444 [PMID: 17681164 DOI: 10.1053/j.gastro.2007.05.014]
62. Sinagra E, Romano C, Cottone M. Psychopharmacological treatment and psychological interventions in irritable bowel syndrome. Gastroenterol Res Pract 2012; 2012: 486067 [PMID: 22956940 DOI: 10.1155/2012/486067]
63. Labus J, Gupta A, Gill HK, Posserud I, Mayer M, Raeen H, Bolus R, Simren M, Naliboff BD, Mayer EA. Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention. Aliment Pharmacol Ther 2013; 37: 304-315 [PMID: 23205588 DOI: 10.1111/apt.12171]
64. Jarrett ME, Cain KC, Burr RL, Hertig VL, Rosen SN, Heitkemper MM. Comprehensive self-management for irritable bowel syndrome: randomized trial of in-person vs. combined in-person and telephone sessions. Am J Gastroenterol 2009; 104: 3004-3014 [PMID: 19690523 DOI: 10.1038/ajg.2009.479]
65. Everitt H, Moss-Morris R, Sibelli A, Tapp L, Coleman N, Yardley L, Smith P, Little P. Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website. BMC Gastroenterol 2013; 13: 68 [PMID: 23602047 DOI: 10.1186/1471-230x-13-68]
66. Sainsbury A, Ford AC. Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents. Therap Adv Gastroenterol 2011; 4: 115-127 [PMID: 21694813 DOI: 10.1177/ 1756283x10387203]